A 12-month, Open Label, Multicenter Pilot Study Evaluating Fingolimod Treatment in terms of Patient Satisfaction in Relapsing Remitting Multiple Sclerosis Patients - FINE Trial

INTRODUCTION: To assess satisfaction and quality of life in patients with relapsing–remitting multiple sclerosis (RRMS) who were receiving fingolimod (0.5 mg/day) for 12 months as a second-line treatment after switching from injectable agents. METHODS: Patients aged 18–65 years with RRMS who fulfill...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Noro Psikiyatr Ars
Main Authors: Demır, Gülşen Akman, Türkoğlu, Recai, Saıp, Sabahattin, Yüceyar, Nur, Efendı, Hüsnü, Turan, Ömer Faruk, Ağan, Kadriye, Terzı, Murat, Boz, Cavit, Tuncer, Aslı, Koçer, Belgin, Kasap, Mithat, Çalişkan, Zeynep
Formato: Artigo
Idioma:Inglês
Publicado em: Noro-Psikiyatri Arsivi 2017
Assuntos:
Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6927087/
https://ncbi.nlm.nih.gov/pubmed/31903032
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5152/npa.2017.20515
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados